AptaBio Therapeutics (Korea) Performance
| 293780 Stock | 8,450 70.00 0.84% |
On a scale of 0 to 100, AptaBio Therapeutics holds a performance score of 5. The firm shows a Beta (market volatility) of 1.25, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AptaBio Therapeutics will likely underperform. Please check AptaBio Therapeutics' standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether AptaBio Therapeutics' price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in AptaBio Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, AptaBio Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | 1.1 B |
AptaBio |
AptaBio Therapeutics Relative Risk vs. Return Landscape
If you would invest 764,000 in AptaBio Therapeutics on September 2, 2025 and sell it today you would earn a total of 81,000 from holding AptaBio Therapeutics or generate 10.6% return on investment over 90 days. AptaBio Therapeutics is generating 0.2218% of daily returns and assumes 3.3388% volatility on return distribution over the 90 days horizon. Simply put, 29% of stocks are less volatile than AptaBio, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
AptaBio Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AptaBio Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AptaBio Therapeutics, and traders can use it to determine the average amount a AptaBio Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0664
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 293780 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.34 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average AptaBio Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AptaBio Therapeutics by adding it to a well-diversified portfolio.
AptaBio Therapeutics Fundamentals Growth
AptaBio Stock prices reflect investors' perceptions of the future prospects and financial health of AptaBio Therapeutics, and AptaBio Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AptaBio Stock performance.
| Return On Equity | -17.47 | |||
| Return On Asset | -0.0568 | |||
| Operating Margin | (17.13) % | |||
| Current Valuation | 794.49 B | |||
| Shares Outstanding | 10.88 M | |||
| Price To Sales | 926.14 X | |||
| Revenue | 223.68 M | |||
| EBITDA | (6.58 B) | |||
| Cash And Equivalents | 6.57 B | |||
| Total Debt | 46.77 M | |||
| Cash Flow From Operations | (8.9 B) | |||
| Total Asset | 64.91 B | |||
About AptaBio Therapeutics Performance
By analyzing AptaBio Therapeutics' fundamental ratios, stakeholders can gain valuable insights into AptaBio Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AptaBio Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AptaBio Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about AptaBio Therapeutics performance evaluation
Checking the ongoing alerts about AptaBio Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AptaBio Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AptaBio Therapeutics had very high historical volatility over the last 90 days | |
| The company reported the revenue of 223.68 M. Net Loss for the year was (10.69 B) with profit before overhead, payroll, taxes, and interest of 336.97 M. | |
| AptaBio Therapeutics has accumulated about 6.57 B in cash with (8.9 B) of positive cash flow from operations. | |
| Roughly 34.0% of the company shares are owned by insiders or employees |
- Analyzing AptaBio Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AptaBio Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining AptaBio Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AptaBio Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AptaBio Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AptaBio Therapeutics' stock. These opinions can provide insight into AptaBio Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AptaBio Stock analysis
When running AptaBio Therapeutics' price analysis, check to measure AptaBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptaBio Therapeutics is operating at the current time. Most of AptaBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of AptaBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptaBio Therapeutics' price. Additionally, you may evaluate how the addition of AptaBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |